RENPHO Introduces the LYNX Smart Ring Revealing Bonds Between Lifestyle and Wellness
IRVINE, Calif., April 8, 2025 /PRNewswire/ — Leading smart lifestyle tech company, RENPHO, has today announced the wide availability of its LYNX Smart Ring. The LYNX Smart Ring is RENPHO’s first biomonitor, helping users track essential health metrics in a convenient way.
The LYNX Smart Ring helps those looking to gain deeper insight into their well-being with an always-on health tracker that delivers the RENPHO Health App experience anywhere. All tracking metrics from the LYNX Smart Ring seamlessly integrate into the RENPHO Health App, connecting all RENPHO devices within the existing RENPHO ecosystem.
“RENPHO focuses on empowering wellness for all individuals in different phases of their health journey,” said Julia Evers, Head of Marketing at RENPHO. “With the introduction of the LYNX Smart Ring to our product ecosystem, we can provide users with a comprehensive understanding of their physical and mental health, taking wellness to the next level.”
The LYNX Smart Ring comes with a convenient charging case and features waterproof design up to 50 meters. It tracks a variety of health metrics, including:
The LYNX Smart Ring is available on RENPHO.com today in either a titanium or black color finish for $199.99.
About RENPHO
Founded in 2016, RENPHO was born with the vision to empower people worldwide to improve all aspects of their life by granting a passport to their own health data. Its mission is to create a growing ecosystem of smart lifestyle products that provide advanced solutions which are essential, accessible and every day. Widely recognized for its smart weight scales and massage products, RENPHO continues to be a leading innovator in health & wellness technology, developing products that are carefully researched to enhance people’s health, fitness and wellness journey. To learn more, visit RENPHO.com or follow RENPHO on Instagram, X, Facebook, TikTok and LinkedIn.
Media Contact:
Zeno Group
Renpho@zenogroup.com
SOURCE RENPHO
Oncovita receives FDA Orphan Drug Designation for its lead oncolytic virus candidate MVdeltaC in the…
Aortic Stenosis is a Serious and Widespread Condition; The AI-ECG Algorithm Offers a Powerful Diagnostic…
Annamycin delivering better performance 7th line than would be expected even in 2nd line for…
Glucotrack to present on next-generation continuous blood glucose monitoring technology in Innovation Hub Poster presentation…
Supports late-stage development and scalable manufacturing for LP-310, a non-steroidal oral rinse therapy for Oral…
LOS ANGELES, June 04, 2025 (GLOBE NEWSWIRE) -- ViaDerma, Inc. (OTC Expert Market: VDRM), a…